Collaborations & Alliances
-
Breaking News | Collaborations & Alliances
Cellenkos Chooses Cryoport to Support Covid-19 Therapy Shipments to Patients
Cryoport will provide tracking and proactive management for the therapies.06.22.21
-
Breaking News | Collaborations & Alliances
Iksuda, LegoChem Expand ADC Alliance
Grants Iksuda access to LegoChem's next generation ADC platform for up to six targets.06.22.21
-
Collaborations & Alliances | Drug Development
ProBioGen, LAVA to Develop Cell Lines for Bispecific Candidate
ProBioGen will conduct cell line development of a novel gamma-delta bsTCE using its CHO.RiGHT expression platform.06.22.21
-
Breaking News | Collaborations & Alliances | Drug Development
Jacobio Earns $20M AbbVie Milestone
Initiates Phase 1/2a trial of SHP2 inhibitor JAB-3312 in combination with PD-1 antibody Pembrolizumab and MEK inhibitor Binimetinib.06.18.21
-
Breaking News | Collaborations & Alliances | Industry News
KBI Biopharma, AM-Pharma Enter Manufacturing Agreement
Partnership supports future commercial manufacturing for AM-Pharma’s potential kidney disease treatment.06.17.21
-
Breaking News | Collaborations & Alliances | Drug Development | Formulation Development
Lumen Bioscience, Novo Nordisk Enter Metabolic Research Pact
To explore Lumen's drug development and manufacturing platform to deliver oral biologics for cardiometabolic disease.06.16.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
Ocugen, Jubilant Enter COVID-19 Vaccine Partnership
Jubilant HollisterStier to manufacture COVAXIN for the U.S. and Canadian markets.06.15.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
VERAXA and Quadira Enter ADC Development Partnership
To develop a suite of novel ADCs for the treatment of oncological conditions.06.15.21
-
Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development
iTeos Therapeutics, GSK Enter Monoclonal Antibody Alliance
GSK now has a leading portfolio of antibodies targeting the CD226 axis, a key target for next-gen immuno-oncology therapies06.14.21
-
Bio News | Breaking News | Clinical Trial Materials | Clinical Trials | Collaborations & Alliances | Drug Delivery | Industry News | Solid Dosage/Creams/Ointments
Enteris BioPharma Receives $10M Milestone from Cara Therapeutics
Third milestone payment related to the development of Oral KORSUVA.06.11.21
-
Bio News | Breaking News | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News
Revolo and Northway Biotech Enter Manufacturing Partnership
To manufacture novel binding immunoglobulin protein, ‘1805, to support phase 2 trials in rheumatoid arthritis and uveitis.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Drug Development | Industry News
WuXi XDC and LegoChem Ink ADC Agreement
Sign MOU for the development and manufacturing of antibody-drug conjugates.06.11.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
AGC Biologics Inks Supply Deal for COVID-19 Vaccine
CDMO’s Heidelberg facility to supply plasmid DNA for Pfizer/BioNTech COVID-19 vaccine.Tim Wright, Editor, Contract Pharma 06.07.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | cGMP Manufacture | Collaborations & Alliances | Industry News | Process Development
Portonbio Enters CAR-T Partnership with KAEDI
CDMO will provide KAEDI with CMC services for multiple projects.Tim Wright, Editor, Contract Pharma 06.07.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News | Parenterals
Exelead Helps Manufacture Pfizer-BioNTech COVID-19 Vaccine
Pharmaceutical development and manufacturing company delivers first vaccine batch to Pfizer.Tim Wright, Editor, Contract Pharma 06.07.21
-
Breaking News | Collaborations & Alliances | Industry News
PharmaBlock Sciences Partners with Shouyao Holdings
Will support CMC development and manufacturing of Shouyao’s second-generation ALK inhibitor for non-small cell lung cancer.Charles Sternberg, Assistant Editor 06.03.21
-
Bio News | Breaking News | Collaborations & Alliances | Industry News
Samsung Biologics Signs Agreement with Kahr Medical
Will support Kahr’s drug candidate DSP502, a TIGITxPD1 fusion protein.Charles Sternberg, Assistant Editor 06.03.21
-
Breaking News | Collaborations & Alliances | Industry News | Packaging & Tracking | Supply Chain
Alliance to Zero Founded for ‘Green’ Pharma Supply Chain Initiative
Goal is to help pharma sector comply with net-zero emissions in line with the Paris Climate Agreement.Tim Wright, Editor, Contract Pharma 06.03.21
-
Breaking News | Collaborations & Alliances
Aptamer Group Collaborates with PinotBio
Will work together to develop new therapeutic drug conjugates.Charles Sternberg, Assistant Editor 06.02.21
-
Bio News | Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Industry News
CCRM Enters Regenerative Medicine Partnerships
Signs agreements with Canadian and international institutions to advance regenerative medicine inventions.Tim Wright, Editor, Contract Pharma 06.01.21
